The American Diabetes Association and the European Association for the Study of Diabetes have published a 2026 update to their 2021 consensus report on managing type 1 diabetes in adults, in Diabetes Care on 15 September.
The abstract signals where the weight has moved: integration of diabetes technology, interventions to delay the onset of stage 3 type 1 diabetes, and a broader scope that now takes in screening for long-term complications and the management of obesity and cardiovascular risk. Psychosocial care and structured self-management education remain core elements.
The shift that matters most for an adult clinic is the explicit treatment of obesity and cardiovascular risk as part of type 1 care rather than something borrowed from type 2 practice. Read the full document before changing local protocols; the abstract does not give the individual recommendations or their evidence grades.
- Check whether your adult type 1 clinic has a documented pathway for obesity and cardiovascular risk, not only glycaemia.
- Review how technology (CGM, automated insulin delivery) is offered and who is missed.
- Confirm complication screening intervals are recorded for every adult with type 1 diabetes.
- Keep psychosocial screening and structured education on the annual review template.
Why it matters
Adult type 1 care is now expected to cover obesity and cardiovascular risk, not just insulin and glucose.
Don't overread it
The abstract gives the scope of the update, not its specific recommendations or evidence grades.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free